LY2880070
Product Specifications
UNSPSC Description
LY2880070 is an orally active CHK1 inhibitor, IC50 [1][2].
Target Antigen
Checkpoint Kinase (Chk)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ly2880070.html
Solubility
DMSO : 160 mg/mL (ultrasonic)
Smiles
COC1=C(C=CC(C)=N1)C2=CC(NC3=NC(O[C@@H]4CCCNC4)=CN=C3)=NN2
Molecular Weight
381.43
References & Citations
[1]Quincy S, et al. A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine in patients with advanced or metastatic cancer. Journal of Clinical Oncology 2020 38:15_suppl, 3581.|[2]Kailong Jiang, et al. Functions and inhibitors of CHK1 in cancer therapy. Medicine in Drug Discovery. Volume 22, June 2024, 100185.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148962/LY2880070-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148962/LY2880070-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1375637-35-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC212424L1V 200 µL
EHM2 (EPB41L4B) (NM_019114) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details